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health, Mental health, Sexuality, and Couple Relationship, being the first dimen-
sion composed by 3 sub-dimensions: vasomotor symptoms, health, and Aging. 
Goodness-of-fit statistics were better than those of the extended version (chi-
square/df= 2.130, AGFI= 0.859, PCFI= 0.919, RMSEA= 0.044). Internal consistency was 
good (Cronbach’s alpha= 0.830) but slightly lower than that of the original scale. 
Correlations between extended and reduced subscales was high and significant in 
all cases (p< 0.001), ranging from r= 0.857 for Aging to r= 0.971 for Vasomotor symp-
toms. ConClusions: The Cervantes scale may be reduced to an abridged version 
of 14-item (Cervantes-SF) which maintains the original dimensional structure and 
psychometric properties. This version extends 45% of the original length, being 
faster to apply and making it specially suitable for routine medical practice.
PIH49
Value attrIbutes of GenerIc Versus branded druGs In são Paulo, 
brazIl
Ferraz M.B., Nardi E.P.
Universidade Federal de São Paulo, Sao Paulo, Brazil
objeCtives: To assess the patients’ and their accompanying family members or car-
ers’ value attributes and perceptions about GD when compared to the corresponding 
brand name drugs (BD). Methods: A total of 25 patients and 25 accompanying 
persons were consecutively selected and interviewed while visiting 6 commercial 
pharmacies located in different regions of São Paulo city. Also 25 patients and 25 
accompanying persons were consecutively selected and interviewed while waiting 
for their regular outpatient visits at the university outpatient clinic. The question-
naire consisted of questions regarding socio-economic, demographic and educa-
tional items, quality of life (QoL), and the interviewee perception regarding the 
value attributes of GD when compared to BD. The study was approved by the local 
ethic committee. Results: Respondents were predominantly women (57%) and 
the mean age was 54 years. Additionally, 55% relied exclusively in public health 
care system and 55% were regularly employed. Mean QoL as assessed by SF-6D was 
0,74. Respondents overwhelmingly (99%) believed GD to be cheaper than BD. Some 
36% and 63% also reported GD to be less and equally effective, respectively, as 
compared to BD. GD were perceived as either safe or less safe than BD in 46% 
and 46%, respectively. Some 74% of the sample agreed with the statement that 
they would prefer to take a BD if there was no price difference to the GD, and 85% 
admitted they regularly compare the prices of BD and GD before deciding which 
drug to buy. ConClusions: Multiple factors may contribute to the decision to buy 
a GD. Among these perceived effectiveness, safety and price appear to be the most 
important factors. Further studies are needed to better understand the decision-
making process regarding GD use and its consequences for the health care system 
and families.
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objeCtives: The Israeli National List of Health Services (NLHS) offers a generous 
coverage for drugs and other technologies. However, not all approved drugs are 
covered under the basic health insurance and are frequently subject to out-of-
pocket payments. We assessed the ex-ante willingness to pay (WTP) for a more 
generous public coverage for life-extending medications. Methods: We con-
ducted a telephone survey among a representative sample of the adult population 
in Israel (n= 502). We asked participants to indicate whether they will be willing to 
pay an increased health tax assuring that all life-extending interventions will be 
covered and provided by their health insurance plans with no cost-sharing. We 
also collected information on respondent age, gender, income, education, self-
rated health and coverage of supplementary/private health insurance. Results: 
Mean age of the study population was 51.7±15.9 years. 63.5% indicated that they 
would be willing-to-pay an increased health tax for a generous public coverage 
of medications. Respondents willing-to-pay were younger (49.3±15.0 vs. 55.9±16.4 
years; p< 0.001), reported a higher self-rated health (p= 0.001), and WTP increased 
with respondent’s income (p= 0.005), and were also covered by a commercial 
health insurance (p= 0.002). Among all respondents (WTP set at zero for those 
unwilling to pay) the median extra monthly WTP was in the range of 0-$7. The 
independent predictors for WTP identified in the logistic regression analysis were: 
respondent age (OR= 0.974; 95% CI 0.960-0.989); and being Jewish (OR= 2.997; 95% CI 
1.745-5.147). ConClusions: Additional sources of funding should be identified 
and allocated to allow a more generous coverage of life-extending medications. 
Respondents are willing-to-pay extra health taxes (up to 7.5% of the current aver-
age health tax) to assure that all life-extending interventions are included in the 
NLHS at no co-payment. While these potential extra funds are sufficient to cover 
a wide range of technologies it is unlikely that the health tax will be raised in 
Israel in the near future.
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objeCtives: To assess WTP of patients and accompanying family members or car-
ers for a brand name drug (BD) as compared to a GD for treating an acute and a 
chronic condition. Methods: A total of 25 patients and 25 accompanying family 
members or carers were consecutively selected and interviewed while visiting 6 
commercial pharmacies located in different regions of São Paulo city. Also another 
25 patients and 25 accompanying family members or carers were consecutively 
selected and interviewed while waiting for their regular outpatient visits at the uni-
versity outpatient clinic. A questionnaire with 2 hypothetical scenarios describing 
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objeCtives: Collecting data about symptoms and health-related quality of life 
impacts in children aged 6-11 is particularly challenging. Children themselves do not 
necessarily have the reading skills or the cognitive and recall capacity to self-report 
on their own, but equally parents are not always with their child or may not observe 
them closely enough and some symptoms are not observable. To overcome these 
challenges we developed a parent-administered child-report symptom measure in 
which the parents helped the child read and understand the PRO items. Methods: 
Iterative rounds of qualitative concept elicitation and cognitive debriefing inter-
views with children (aged 6-11) and parents supported the development and refine-
ment of daily diary instructions, items and response scales. The resulting items 
were included in an observational study of 185 children (aged 6-11) who completed 
the diary at home for seven days in order to support the development of scoring 
and psychometric validation. Feedback on the draft scales was obtained from both 
children and parents following the at-home completion phase, with the parent 
survey and debriefing focusing on how much help they had provided to the children 
in regards to reading, understanding, recalling and responding during the seven 
days. Results: The diary questions were developed to be completed by the child, 
but instructions indicated that the parent could help the child read and understand 
them. Observation of parents helping the child and subsequent debriefing provided 
evidence that parental help aided the child in recalling accurately. However, the 
children did push back if they disagreed with their parent’s suggested response, 
suggesting they were not unduly influenced. Subsequent psychometric validation 
confirmed that this approach and the refined items provided valid, reliable and 
responsive scores. ConClusions: This PRO development provides evidence that 
a parent-assisted child self-report symptom measure had strong content validity 
and was valid, reliable and responsive to changes over time.
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objeCtives: To identify effective reminder strategies, survey data focused on 
patient preferences for reminders in Patient Reported Outcomes (PRO) studies was 
investigated. This presentation will share these results to provide recommenda-
tions for patient reminder strategies to optimize patient compliance and data 
quality. Methods: A survey was completed in 2013, involving patients who par-
ticipated in at least one clinical study in the past two years that required patient 
diaries. The survey sought to establish patient preferences (modality/timing) for 
receiving diary reminders based on their experiences, including an evaluation on 
their personal technology behaviors. Results: Responses were provided by 405 
patients. The patients stated their reasons for non-compliance of their patient 
diaries: 51.4% reported “non-compliance due to forgetting”; 41.1% reported “being 
too busy”; 27.6% reported “a lack of diary access”; and 2.7% reported “other rea-
sons”. Patients also stated their modality preferences for reminders. The preferred 
choice was text messages (67.2%); followed by hand-held alerts (34.3%); phone calls 
(34.1%); calendar alerts (32.6%); and email (6.2%). Although the majority of patients 
indicated checking text messages and emails daily, significantly more patients 
checked text messages immediately when compared to email (52.9% vs. 15.1%) 
suggesting that text messages would be a more effective way to remind patients. 
The majority of patients wanted to be reminded of their diary assessments (97.3%), 
appointments (95.8%), and medication dosing (95.0%). ConClusions: As the top 
reason for non-compliance was “forgetting”, this suggests that reminders can be 
helpful in improving compliance. Results show that patients prefer to be reminded, 
also suggesting that reminders can improve compliance. Technology behaviors 
suggest that text messages could be an effective way to remind patients. Patient 
preferences for reminders should be given careful consideration – since incor-
porating optimal reminder strategies can likely improve the patient experience, 
compliance and data quality.
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objeCtives: The Cervantes scale is a specific health-related-quality-of-life (HRQoL) 
questionnaire developed in Spanish women through and beyond menopause. The 
original scale contains 31-items and it is time-consuming in the routine medical 
practice. The aim of this work was to reduce the 31-item scale and to produce an 
abridged version with the same dimensional structure and similar psychometric 
properties. Methods: A representative sample of 563 women [mean age 60 years 
old (SD= 6.7, Min= 46, Max= 82)] extracted from the Ginerisk study was used. The 
Ginerisk was an epidemiological, cross-sectional study carried out in 4,157 Spanish 
post-menopausal women attending out-patient clinics of Gynecology throughout 
Spain in year 2011. Item analysis, internal consistency reliability, item-total and 
item-domain correlations and item correlation with the generic Spanish version 
of the MOS-SF12v2 questionnaire dimensions were initially studied. Dimensional 
Confirmatory Factor Analysis (CFA) and Full-model CFA were used to check struc-
ture stability. A 3-fold cross-validation method was used to obtain stable estimates, 
by means of multi-group analysis. Results: The scale was reduced to a 14-items 
version: The Cervantes-SF, containing four main dimensions: Menopause and 
